# Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rapamycin-inhibits-primary-and-metastatic-tumor-growth-by-antiangiogenesis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Markus Guba,Philipp von Breitenbuch,Markus Steinbauer,Gudrun E. Koehl,Stefanie Flegel,Matthias Hornung,Christiane J. Bruns,Carl Zuelke,Stefan Farkas,Matthias Anthuber,Karl‐Walter Jauch,Edward K. Geissler |
| Citations | 1,738 |
| DOI | 10.1038/nm0202-128 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2026351725 |
| PMID | 11821896 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Christiane J. Bruns](https://scholariq.org/researchers/christiane-j-bruns/)
- [Markus Steinbauer](https://scholariq.org/researchers/markus-steinbauer/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.